Xinyu Du Selected Research

Xinyu Du Research Topics

Disease

3	Inflammation (Inflammations) 12/2022 - 10/2016
2	Breast Neoplasms (Breast Cancer) 09/2023 - 09/2023
2	Pathologic Constriction (Stenosis) 08/2023 - 08/2022
2	Crohn Disease (Crohn's Disease) 08/2023 - 08/2022
2	Hepatitis C 03/2023 - 08/2022
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 05/2021
2	Diarrhea 12/2022 - 09/2022
2	Infections 12/2022 - 09/2022
1	Cerebral Hemorrhage 03/2024
1	Colitis 12/2023
1	Colonic Neoplasms (Colon Cancer) 09/2023
1	Polyps 09/2023
1	Myocardial Infarction 05/2023
1	Autoimmune Diseases (Autoimmune Disease) 03/2023
1	Rheumatoid Arthritis 03/2023
1	Osteoporosis 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Poisoning 10/2022
1	Rhabdomyolysis 10/2022
1	Disease Progression 08/2022
1	Death (Near-Death Experience) 07/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Atherosclerosis 03/2021
1	Ischemic Stroke 03/2021
1	Reperfusion Injury 03/2021
1	Stroke (Strokes) 03/2021
1	Cognitive Dysfunction 01/2021
1	Substance-Related Disorders (Drug Abuse) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Shock 03/2020

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2021
2	Antihypertensive Agents (Antihypertensives)IBA 03/2024 - 01/2022
2	OligosaccharidesIBA 08/2023 - 08/2022
2	carboxymethyl-chitosanIBA 08/2023 - 08/2022
2	omega-Chloroacetophenone (Mace)IBA 05/2023 - 01/2023
2	Antiviral Agents (Antivirals)IBA 03/2023 - 08/2022
2	ZincIBA 12/2022 - 09/2022
1	Remifentanil (Ultiva)FDA Link 03/2024
1	Dexmedetomidine FDA Link 03/2024
1	Carotenoids (Carotene)IBA 12/2023
1	ApolipoproteinsIBA 09/2023
1	Serine-tRNA LigaseIBA 09/2023
1	Phenobarbital (Luminal)FDA Link 09/2023
1	ORALIT (ORS)IBA 09/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2023
1	SeleniumIBA 01/2023
1	CadmiumIBA 01/2023
1	Heavy MetalsIBA 01/2023
1	AcidsIBA 10/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2022
1	DiquatIBA 10/2022
1	GlucocorticoidsIBA 10/2022
1	MyoglobinIBA 10/2022
1	Virulence Factors (Pathogenicity Factors)IBA 09/2022
1	Enterotoxins (Enterotoxin)IBA 09/2022
1	Ethanol (Ethyl Alcohol)IBA 08/2022
1	SolutionsIBA 08/2022
1	Trinitrobenzenesulfonic AcidIBA 08/2022
1	Mesalamine (Mesalazine)FDA LinkGeneric 08/2022
1	MicroplasticsIBA 07/2022
1	Circular RNAIBA 03/2021
1	MicroRNAs (MicroRNA)IBA 03/2021
1	Ghrelin ReceptorsIBA 01/2021
1	N- (1- (4- (4- methoxybenzyl)- 5- phenethyl- 4H- 1,2,4- triazol- 3- yl)- 2- (1H- indol- 3- yl)ethyl)- 2- aminoacetamideIBA 01/2021
1	Thiamine PyrophosphateIBA 01/2021
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 01/2021
1	CytokinesIBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 10/2016
1	Interleukin-17 (Interleukin 17)IBA 10/2016

Therapy/Procedure

1	Injections 12/2023
1	Continuous Renal Replacement Therapy 10/2022
1	Aftercare (After-Treatment) 10/2022
1	Hemoperfusion 10/2022
1	Enema (Enemas) 08/2022
1	Therapeutics 08/2022
1	Drug Therapy (Chemotherapy) 03/2021
1	Surgical Instruments (Clip) 03/2020